Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Current Deferred Revenue (2022 - 2025)

Stemtech (STEK) has disclosed Current Deferred Revenue for 4 consecutive years, with $88393.0 as the latest value for Q3 2025.

  • Quarterly Current Deferred Revenue changed N/A to $88393.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $88393.0 through Sep 2025, changed N/A year-over-year, with the annual reading at $1463.0 for FY2024, 97.39% down from the prior year.
  • Current Deferred Revenue hit $88393.0 in Q3 2025 for Stemtech, down from $98249.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $98249.0 in Q2 2025 to a low of $1463.0 in Q4 2024.
  • Historically, Current Deferred Revenue has averaged $61533.5 across 4 years, with a median of $75907.0 in 2023.
  • Biggest YoY gain for Current Deferred Revenue was 75.49% in 2024; the steepest drop was 97.39% in 2024.
  • Year by year, Current Deferred Revenue stood at $39170.0 in 2022, then skyrocketed by 43.07% to $56039.0 in 2023, then crashed by 97.39% to $1463.0 in 2024, then skyrocketed by 5941.9% to $88393.0 in 2025.
  • Business Quant data shows Current Deferred Revenue for STEK at $88393.0 in Q3 2025, $98249.0 in Q2 2025, and $6778.0 in Q1 2025.